Latest News

As the U.S. stock market navigates a period of cautious optimism following recent inflation data and mixed corporate earnings, investors are increasingly focused on identifying resilient growth opportunities. In this context, companies with high insider ownership often stand out as promising candidates, suggesting that those who know the business best have confidence in its future prospects.

As the U.S. stock market experiences a pullback with investors assessing CPI inflation data and major bank earnings, attention turns to alternative investment opportunities like penny stocks. Often considered an outdated term, penny stocks still hold relevance as they represent smaller or newer companies that can offer growth potential at lower price points. When these companies are backed by strong financial fundamentals, they present intriguing options for investors seeking hidden value in...

As the U.S. market navigates a landscape marked by recent inflation data and fluctuating key indices, investors are closely monitoring the performance of small-cap stocks within the S&P 600. With economic indicators showing resilience amid cautious optimism, identifying promising opportunities in lesser-known stocks can be crucial for those seeking to capitalize on potential growth. In this environment, a good stock often exhibits strong fundamentals and adaptability to changing economic...

Despite an already strong run, Planet Labs PBC ( NYSE:PL ) shares have been powering on, with a gain of 39% in the last...

The Mosaic Company has entered into a definitive agreement to sell its Carlsbad, New Mexico potash operation to International Minerals Carlsbad for US$30,000,000, refocusing its potash production in Saskatchewan, Canada. This divestment marks a clear shift toward concentrating capital on higher-return potash assets, potentially altering Mosaic’s long-term operations mix and risk profile. We’ll now examine how concentrating potash production in Saskatchewan might influence Mosaic’s existing...

Planisware SAS (ENXTPA:PLNW) has caught investor attention after recent share price moves, with the stock showing mixed short term returns and a stronger performance over the past 3 months. See our latest analysis for Planisware SAS. The recent pullback in Planisware SAS, with a 1-day share price return of 0.44% decline and a 7-day share price return of 1.72% decline at a €22.85 share price, sits alongside a 30-day share price return of 8.29% and a 90-day share price return of 15.99%. The...

BMO Capital recently initiated coverage on Crescent Energy with a Market Perform rating, highlighting improved margins and a leaner asset base but also describing 2026 as a transition year marked by declining legacy Vital production and slower balance sheet de-leveraging amid softer oil prices. Crescent Energy also previously announced it will discuss its fourth-quarter 2025 and full-year results, along with its 2026 outlook, on a February 2026 call, which may clarify how management plans to...

Why A2A (BIT:A2A) is back on investors’ radar A2A (BIT:A2A) is drawing fresh attention after reaffirming its capital expenditure plans for renewables and grid modernization, even as broader markets contend with macroeconomic volatility and shifting sentiment toward European utilities. See our latest analysis for A2A. That renewed focus on renewables is landing on a share price of €2.399, with a 7 day share price return of 4.1% and a year to date share price return of 3.7%. The 1 year total...

Why the latest update on Matador Resources (MTDR) matters Recent commentary around Matador Resources (MTDR) centers on its third quarter 2025 results, where net income, Delaware Basin production, and midstream revenues all featured prominently, alongside continued spending on drilling and San Mateo midstream expansion. See our latest analysis for Matador Resources. MTDR's third quarter 2025 update comes after a mixed share price run, with the latest close at US$41.89, a 30 day share price...

The latest move in Fortune Brands Innovations (FBIN) comes after news of a planned US$200b U.S. mortgage bond buying program, a policy aimed at housing affordability that quickly pulled investor focus toward housing related names. See our latest analysis for Fortune Brands Innovations. That policy driven surge comes on top of a 7 day share price return of 15.93% and a 90 day share price return of 19.05%. However, the 1 year total shareholder return is still a 14.69% decline, suggesting recent...

QuantumScape’s manufacturing upgrade and why it matters for investors QuantumScape (QS) reported that its Cobra ceramic separator process is now the standard in its solid-state lithium-metal battery manufacturing, improving production efficiency, supporting potential gigafactory-scale output, and targeting longer battery life, faster charging, and lower costs. See our latest analysis for QuantumScape. Despite excitement around the Cobra process, QuantumScape’s recent trading has been choppy,...

Healthpeak Properties (DOC) recently outlined about US$925 million of transaction activity, including a US$600 million purchase of a 1.4 million square foot South San Francisco campus, along with roughly US$325 million of outpatient medical property sales. See our latest analysis for Healthpeak Properties. The recent acquisition and disposals have come alongside a 7 day share price return of 2.56% and a 90 day share price return decline of 7.33%, while the 1 year total shareholder return...

In recent days, Wells Fargo and RBC Capital have each begun or renewed coverage of Phreesia, assigning favorable ratings that highlight its role as a healthcare technology provider with a SaaS-based patient intake platform. This wave of positive analyst attention points to growing institutional focus on how Phreesia’s software, used across thousands of physicians, could influence its growth profile and profitability efforts. Next, we’ll examine how this increase in supportive analyst...

Merit Medical Systems recently issued fourth-quarter 2025 earnings guidance, projecting revenue between US$389,000,000 and US$395,000,000 year-over-year, and confirmed a Board leadership change with F. Ann Millner appointed Chair following the resignation of longtime director and former Chair Fred P. Lampropoulos. This combination of updated revenue expectations and a shift in Board leadership brings fresh attention to how Merit balances growth ambitions with governance continuity. Next, we...

Conference appearance and recent rating change put Kinetik in focus Kinetik Holdings (KNTK) is drawing fresh attention after presenting at the UBS Global Energy & Utilities Winter Conference in Park City, Utah, shortly after a Raymond James upgrade to Outperform. See our latest analysis for Kinetik Holdings. Despite the recent conference appearance and upgrade, Kinetik’s 1 year total shareholder return decline of 35.4% contrasts with a 43.0% gain over three years, suggesting longer term...

In recent months, Evolv Technologies Holdings reported strong quarterly results, including a 57% year-over-year revenue increase, positive adjusted EBITDA, and raised full-year 2025 revenue guidance, while CEO John Kedzierski sold 74,322 shares after exercising 207,000 options primarily to cover tax obligations. Despite the insider sale reducing his direct ownership by about 34.57%, Kedzierski still retains a significant stake, aligning leadership incentives with shareholders as Evolv’s...

Axcelis Technologies overview and recent performance context Axcelis Technologies (ACLS) has attracted attention after a period of mixed financial trends, with annual revenue growth of 2.99% and a 13.63% decline in net income, prompting investors to reassess the current share price of $95.72. See our latest analysis for Axcelis Technologies. Recent trading has been positive, with a 1 month share price return of 11.81% and a 90 day share price return of 14.27%. The 1 year total shareholder...

Edenred recently issued a €500 million bond maturing in January 2033 with a 3.75% coupon, attracting demand of over €1.60 billion from international institutional investors and using the proceeds mainly to refinance a bond due in March 2026. This oversubscribed issue extends Edenred’s average bond maturity to 4.1 years and underpins funding for its Amplify25-28 growth plan. Next, we’ll examine how this strongly oversubscribed €500 million bond issue may influence Edenred’s investment...

UWM Holdings (UWMC) is back in focus after President Donald Trump announced a US$200b federal program to buy mortgage backed securities. The move is aimed at influencing mortgage rates outside the Federal Reserve’s actions. See our latest analysis for UWM Holdings. The news-driven jump in UWM’s share price sits against mixed recent performance, with a 20% 7 day share price return, a 21.09% year to date share price return, and a 68.11% 3 year total shareholder return. This suggests momentum...

Citizens’ new coverage of PulteGroup (PHM), paired with recent federal limits on institutional single family home purchases, has pushed the homebuilder into focus for investors tracking policy sensitive housing names. See our latest analysis for PulteGroup. The recent federal cap on institutional single family purchases and Citizens’ upbeat initiation have arrived alongside an 11.15% 7 day share price return and a 23.22% 1 year total shareholder return. This suggests momentum has recently...

Asset sales and analyst sentiment put Federal Realty Investment Trust (FRT) in focus Federal Realty Investment Trust (FRT) is drawing fresh attention as it raises funds through asset sales to support future growth, while analysts maintain a moderate buy rating that keeps sentiment broadly constructive around the stock. See our latest analysis for Federal Realty Investment Trust. The share price, which last closed at US$101.80, has been edging higher recently, with a 90 day share price return...

ImmunityBio’s ANKTIVA lung cancer data and what it means for investors ImmunityBio (IBRX) reported statistically significant immune restoration and a link between lymphocyte recovery and survival in non small cell lung cancer from its ANKTIVA clinical program, based on the QUILT-2.023 and QUILT-3.055 studies. The company highlighted results across 151 checkpoint experienced patients who had progressed after standard treatments, describing these data as foundational safety and efficacy...

CAVA Group, Inc. recently appointed veteran operator Doug Thompson as Chief Operations Officer, effective March 2, 2026, and earlier this month rolled out its largest-ever nationwide Mediterranean menu update, featuring new high-protein bowls, sides, drinks, and the return of white sweet potato. Together, the leadership hire and expanded menu highlight CAVA’s emphasis on sharpening restaurant operations while broadening its offering to keep guests engaged as it scales. We’ll now examine how...

Penske Automotive Group, Inc.'s ( NYSE:PAG ) price-to-earnings (or "P/E") ratio of 11.5x might make it look like a buy...